Patents/Assignees

Lung Therapeutics, Inc.

2 patents in portfolio

US11905336utility2024
Modified Peptide Fragments of CAV-1 Protein and the Use Thereof in the Treatment of Fibrosis
0 cites
US11787838utility2023
Modified Peptide Fragments of CAV-1 Protein and the Use Thereof in the Treatment of Fibrosis
0 cites